Abstract
BCL-2 gene as well as its products is recognized as a promising target for the molecular targeted therapy of tumors. However, due to certain defense measures of tumor cells, the therapeutic effect based on the gene silencing of BCL-2 is greatly reduced. Here we fabricate a smart response nucleic acid therapeutic that could silence the gene effectively through a dual-targeted and cascade-enhanced strategy. In brief, nano-graphene oxide (GO), working as a nano-carrier, is loaded with a well-designed DNAzyme, which can target and silence the BCL-2 mRNA. Furthermore, upon binding with the BCL-2 mRNA, the enzymatic activity of the DNAzyme can be initiated, cutting a substrate oligonucleotide to produce an anti-nucleolin aptamer AS1411. Nucleolin, a nucleolar phosphoprotein, is known as a stabilizer of BCL-2 mRNA. Via binding and inactivating the nucleolin, AS1411 can destabilize BCL-2 mRNA. By this means of simultaneously targeting mRNA and its stabilizer in an integrated system, effective silencing of the BCL-2 gene of tumor cells is achieved at both the cellular and in vivo levels. After being dosed with this nucleic acid therapeutic and without any chemotherapeutics, apoptosis of tumor cells at the cellular level and apparent shrinkage of tumors in vivo are observed. By labeling a molecular beacon on the substrate of DNAzyme, visualization of the enzymatic activity as well as the tumor in vivo can be also achieved. Our work presents a pure bio-therapeutic strategy that has positive implications for enhancing tumor treatment and avoiding side effects of chemotherapeutics.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Delbridge, A. R. D.; Strasser, A. The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ.2015, 22, 1071–1080.
Pettersson, M.; Jernberg-Wiklund, H.; Larsson, L. G.; Sundstrom, C.; Givol, I.; Tsujimoto, Y.; Nilsson, K. Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood1992, 79, 495–502.
Ma, L. Y.; Han, M.; Keyoumu, Z.; Wang, H.; Keyoumu, S. Immunotherapy of dual-function vector with both immunostimulatory and B-cell lymphoma 2 (Bcl-2)-silencing effects on gastric carcinoma. Med. Sci. Monit.2017, 23, 1980–1991.
Du, Y.; Ji, X. K. Bcl-2 down-regulation by small interfering RNA induces Beclin1-dependent autophagy in human SGC-7901 cells. Cell Biol. Int.2014, 38, 1155–1162.
Konopleva, M.; Letai, A. BCL-2 inhibition in AML: An unexpected bonus? Blood2018, 132, 1007–1012.
Bhola, P. D.; Letai, A. Mitochondria-judges and executioners of cell death sentences. Mol. Cell2016, 61, 695–704.
Fesik, S. W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer2005, 5, 876–885.
Yang, W. Q.; Zhang, Y. RNAi-mediated gene silencing in cancer therapy. Expert Opin. Biol. Ther.2012, 12, 1495–1504.
Chen, X. X.; Chen, T. S.; Ren, L. J.; Chen, G. F.; Gao, X. H.; Li, G. X.; Zhu, X. L. Triplex DNA nanoswitch for pH-sensitive release of multiple cancer drugs. ACS Nano2019, 13, 7333–7344.
Tai, W. Y.; Li, J. W.; Corey, E.; Gao, X. H. A ribonucleoprotein octamer for targeted siRNA delivery. Nat. Biomed. Eng.2018, 2, 326–337.
Tai, W. Y.; Gao, X. H. Functional peptides for siRNA delivery. Adv. Drug Deliv. Rev.2017, 110–111, 157–168.
Karnati, H. K.; Yalagala, R. S.; Undi, R.; Pasupuleti, S. R.; Gutti, R. K. Therapeutic potential of siRNA and DNAzymes in cancer. Tumor Biol.2014, 35, 9505–9521.
Liao, Z. X.; Chuang, E. Y.; Lin, C. C.; Ho, Y. C.; Lin, K. J.; Cheng, P. Y.; Chen, K. J.; Wei, H. J.; Sung, H. W. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumorspecific chemotherapy that overcomes multidrug resistance. J. Control. Release2015, 208, 42–51.
Zhang, J. J.; Lan, T.; Lu, Y. Molecular engineering of functional nucleic acid nanomaterials toward in vivo applications. Adv. Healthc. Mater.2019, 8, 1801158.
Chen, X. X.; Zhao, J.; Chen, T. S.; Gao, T.; Zhu, X. L.; Li, G. X. Nondestructive analysis of tumor-associated membrane protein integrating imaging and amplified detection in situ based on dual-labeled DNAzyme. Theranostics2018, 8, 1075–1083.
Otake, Y.; Soundararajan, S.; Sengupta, T. K.; Kio, E. A.; Smith, J. C.; Pineda-Roman, M.; Stuart, R. K.; Spicer, E. K.; Fernandes, D. J. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood2007, 109, 3069–3075.
Soundararajan, S.; Chen, W.; Spicer, E. K.; Courtenay-Luck, N.; Fernandes, D. J. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res.2008, 68, 2358–2365.
Ishimaru, D.; Zuraw, L.; Ramalingam, S.; Sengupta, T. K.; Bandyopadhyay, S.; Reuben, A.; Fernandes, D. J.; Spicer, E. K. Mechanism of regulation of bcl-2 mRNA by nucleolin and a plus U-rich element-binding factor 1 (AUF1). J. Biol. Chem.2010, 285, 27182–27191.
He, Z. M.; Zhang, P. H.; Li, X.; Zhang, J. R.; Zhu, J. J. A targeted DNAzyme-nanocomposite probe equipped with built-in Zn2+ arsenal for combined treatment of gene regulation and drug delivery. Sci. Rep.2016, 6, 22737.
Oun, R.; Moussa, Y. E.; Wheate, N. J. The side effects of platinum-based chemotherapy drugs: A review for chemists. Dalton Trans.2018, 47, 6645–6653.
Lawrie, T. A.; Gillespie, D.; Dowswell, T.; Evans, J.; Erridge, S.; Vale, L.; Kernohan, A.; Grant, R. Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma. Cochrane Database Syst. Rev.2019, 8, CD013047.
Cho, E. A.; Moloney, F. J.; Cai, H.; Au-Yeung, A.; China, C.; Scolyer, R. A.; Yosufi, B.; Raftery, M. J.; Deng, J. Z.; Morton, S. W. et al. Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: A phase 1 first-in-human trial (DISCOVER). Lancet2013, 381, 1835–1843.
Santoro, S. W.; Joyce, G. F. A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. USA1997, 94, 4262–4266.
Wang, H. M.; Chen, Y. Q.; Wang, H.; Liu, X. Q.; Zhou, X.; Wang, F. DNAzyme-loaded metal–organic frameworks (MOFs) for self-sufficient gene therapy. Angew. Chem., Int. Ed.2019, 58, 7380–7384.
Qu, X. M.; Yang, F.; Chen, H.; Li, J.; Zhang, H. B.; Zhang, G. J.; Li, L.; Wang, L. H.; Song, S. P.; Tian, Y. et al. Bubble-mediated ultrasensitive multiplex detection of metal ions in three-dimensional DNA nanostructure-encoded microchannels. ACS Appl. Mater. Interfaces2017, 9, 16026–16034.
Su, Y. W.; Li, D.; Liu, B. Y.; Xiao, M. S.; Wang, F.; Li, L.; Zhang, X. L.; Pei, H. Rational design of framework nucleic acids for bioanalytical applications. ChemPlusChem2019, 84, 512–523.
Xiao, M. S.; Lai, W.; Man, T. T.; Chang, B. B.; Li, L.; Chandrasekaran, A. R.; Pei, H. Rationally engineered nucleic acid architectures for biosensing applications. Chem. Rev.2019, 119, 11631–11717.
Bakshi, S. F.; Guz, N.; Zakharchenko, A.; Deng, H.; Tumanov, A. V.; Woodworth, C. D.; Minko, S.; Kolpashchikov, D. M.; Katz, E. Magnetic field-activated sensing of mRNA in living cells. J. Am. Chem. Soc.2017, 139, 12117–12120.
Kim, S.; Ryoo, S. R.; Na, H. K.; Kim, Y. K.; Choi, B. S.; Lee, Y.; Kim, D. E.; Min, D. H. Deoxyribozyme-loaded nano-graphene oxide for simultaneous sensing and silencing of the hepatitis C virus gene in liver cells. Chem. Commun.2013, 49, 8241–8243.
Somasuntharam, I.; Yehl, K.; Carroll, S. L.; Maxwell, J. T.; Martinez, M. D.; Che, P. L.; Brown, M. E.; Salaita, K.; Davis, M. E. Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction. Biomaterials2016, 83, 12–22.
Tian, B.; Wang, C.; Zhang, S.; Feng, L. Z.; Liu, Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano2011, 5, 7000–7009.
Feng, L. Z.; Liu, Z. Graphene in biomedicine: Opportunities and challenges. Nanomedicine2011, 6, 317–324.
Wang, Y.; Li, Z. H.; Hu, D. H.; Lin, C. T.; Li, J. H.; Lin, Y. H. Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells. J. Am. Chem. Soc.2010, 132, 9274–9276.
Bennett, C. F. Therapeutic antisense oligonucleotides are coming of age. Annu. Rev. Med.2019, 70, 307–321.
Dam, D. H. M.; Lee, J. H.; Sisco, P. N.; Co, D. T.; Zhang, M.; Wasielewski, M. R.; Odom, T. W. Direct observation of nanoparticle–cancer cell nucleus interactions. ACS Nano2012, 6, 3318–3326.
Fan, H. H.; Zhao, Z. L.; Yan, G. B.; Zhang, X. B.; Yang, C.; Meng, H. M.; Chen, Z.; Liu, H.; Tan, W. H. A smart DNAzyme-MnO2 nanosystem for efficient gene silencing. Angew. Chem., Int. Ed.2015, 54, 4801–4805.
Bagheri, Z.; Ranjbar, B.; Latifi, H.; Zibaii, M. I.; Moghadam, T. T.; Azizi, A. Spectral properties and thermal stability of AS1411 G-quadruplex. Int. J. Biol. Macromol.2015, 72, 806–811.
Butovskaya, E.; Soldà, P.; Scalabrin, M.; Nadai, M.; Richter, S. N. HIV-1 nucleocapsid protein unfolds stable RNA G-quadruplexes in the viral genome and is inhibited by G-quadruplex ligands. ACS Infect. Dis.2019, 5, 2127–2135.
Yang, K.; Feng, L. Z.; Liu, Z. Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy. Adv. Drug Deliv. Rev.2016, 105, 228–241.
Shi, L.; Mu, C. L.; Gao, T.; Chai, W. X.; Sheng, A. Z.; Chen, T. S.; Yang, J.; Zhu, X. L.; Li, G. X. Rhodopsin-like ionic gate fabricated with graphene oxide and isomeric DNA switch for efficient photocontrol of ion transport. J. Am. Chem. Soc.2019, 141, 8239–8243.
Yang, K.; Feng, L. Z.; Shi, X. Z.; Liu, Z. Nano-graphene in biomedicine: Theranostic applications. Chem. Soc. Rev.2013, 42, 530–547.
Pan, W. Y.; Huang, C. C.; Lin, T. T.; Hu, H. Y.; Lin, W. C.; Li, M. J.; Sung, H. W. Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites. Nanomedicine2016, 12, 431–438.
Zhu, X. L.; Shen, Y. L.; Cao, J. P.; Yin, L.; Ban, F. F.; Shu, Y. Q.; Li, G. X. Detection of microRNA SNPs with ultrahigh specificity by using reduced graphene oxide-assisted rolling circle amplification. Chem. Commun.2015, 51, 10002–10005.
Zhu, X. L.; Sun, L. Y.; Chen, Y. Y.; Ye, Z. H.; Shen, Z. M.; Li, G. X. Combination of cascade chemical reactions with graphene-DNA interaction to develop new strategy for biosensor fabrication. Biosens. Bioelectron.2013, 47, 32–37.
Liu, Z.; Winters, M.; Holodniy, M.; Dai, H. J. siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew. Chem., Int. Ed.2007, 46, 2023–2027.
Liu, Z.; Fan, A. C.; Rakhra, K.; Sherlock, S.; Goodwin, A.; Chen, X. Y.; Yang, Q. W.; Felsher, D. W.; Dai, H. J. Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew. Chem., Int. Ed.2009, 48, 7668–7672.
Zhu, X. L.; Zhang, H. H.; Feng, C.; Ye, Z. H.; Li, G. X. A dualcolorimetric signal strategy for DNA detection based on graphene and DNAzyme. RSC Adv.2014, 4, 2421–2426.
Zhu, X. L.; Zhang, B.; Ye, Z. H.; Shi, H.; Shen, Y. L.; Li, G. X. An ATPresponsive smart gate fabricated with a graphene oxide-aptamer-nanochannel architecture. Chem. Commun.2015, 51, 640–643.
Yang, K.; Zhang, S.; Zhang, G. X.; Sun, X. M.; Lee, S. T.; Liu, Z. Graphene in mice: Ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett.2010, 10, 3318–3323.
Yang, K.; Wan, J. M.; Zhang, S.; Tian, B.; Zhang, Y. J.; Liu, Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials2012, 33, 2206–2214.
Perrone, R.; Butovskaya, E.; Lago, S.; Garzino-Demo, A.; Pannecouque, C.; Palù, G.; Richter, S. N. The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell. Int. J. Antimicrob. Agents2016, 47, 311–316.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No. 21575088) and the Natural Science Foundation of Shanghai (No. 19ZR1474200).
Author information
Authors and Affiliations
Corresponding authors
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Ren, L., Chen, X., Feng, C. et al. Visualized and cascade-enhanced gene silencing by smart DNAzyme-graphene nanocomplex. Nano Res. 13, 2165–2174 (2020). https://doi.org/10.1007/s12274-020-2826-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12274-020-2826-5